Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Abstract
In vivo microdialysis was used to assess the involvement of ventral tegmental area (VTA) mu, delta, and kappa opioid receptors in modulation of basal extracellular ventral striatal dopamine (DA) and DA-metabolite concentrations. Independent groups of chloral hydrate-anesthetized rats were given VTA microinjections of selective opioid agonists, and extracellular ventral striatal DA and DA-metabolite concentrations were assayed using HPLC. VTA microinjections of [D-Ala2, N-Me-Phe4-Gly5-ol]-enkephalin (DAMGO; a mu agonist) and [D-Pen2, D-Pen5]-enkephalin (DDDPE; a delta agonist) each caused dose-orderly increases in ventral striatal DA and DA-metabolite concentrations. The effective concentrations of DPDPE were 100- to 1000-fold higher than the effective concentrations of DAMGO. VTA microinjections of (trans-(dl)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclo-hexyl]- benzeneacetamide) methane sulfonate hydrate (U-50,488H); a kappa agonist) failed to alter ventral striatal DA concentrations at any dose tested, but subsequent systemic injections significantly decreased DA and DA-metabolite concentrations. Pretreatment with VTA microinjections of 17-cyclopropylmethyl-6,7-dehydro-4,5-epoxy-3,14-dihydroxy-6,7,2',3'- indolmorphinan hydrochloride (naltrindole; a delta antagonist) (delta antagonist) antagonized VTA DPDPE-mediated increases in ventral striatal DA and DA-metabolite concentrations but failed to antagonize VTA DAMGO-mediated increases. Pretreatment with D-Pen-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP; a mu antagonist) antagonized VTA DAMGO-mediated increases but failed to antagonize VTA DPDPE-mediated increases. Thus both mu and delta receptor agonist appear capable of increasing ventral striatal DA and DA-metabolite concentrations through selective actions on their preferred class of opioid receptors in the VTA. The increases in ventral striatal DA and DA-metabolite concentrations that are seen after systemic treatment with kappa opioid agonists appear not to involve VTA opioid receptors.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Dynorphins decrease and enkephalins increase the release of DA.
“In particular, dynorphins decrease and enkephalins increase the release of DA (Devine et al. 1993; Di Chiara & Imperato 1988; Longoni et al. 1991; Pentney & Gratton 1991; Spanagel et al. 1990a,b, 1992).”
From Reward, addiction, withdrawal to nicotine (2011) · cites this paper as Devine et al. 1993
The correlation of one OPRM1 SNP and DRD2 variation with community integration may reflect known interactions between the dopamine and endorphin systems in both humans and rodents, whereby endorphin activation may itself trigger a dopamine response.
“may reflect known interactions between the dopamine and endorphin systems in both humans and rodents (40, 55, 56), whereby endorphin activation may itself trigger a dopamine response”
From Variation in the β-endorphin, oxytocin, and dopamine receptor genes is associated with different dimensions of human sociality (2017) · cites this paper as [56]
Cites
Still being checked.
Cited by
Sorted by citations
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,337 · see citing works
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072 · see citing works
Self-citationMotivation, emotion, and their inhibitory control mirrored in brain oscillations
Knyazev, G. G. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.10.004 · Cited by 979 · see citing works
Wise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881 · see citing works
Self-citationAddictive Drugs and Brain Stimulation Reward
Wise, R. A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001535 · Cited by 792 · see citing works
Self-citationEEG delta oscillations as a correlate of basic homeostatic and motivational processes
Knyazev, G. G. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.002 · Cited by 776 · see citing works
Drug-activation of brain reward pathways
Wise, R. A. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00063-5 · Cited by 684 · see citing works
Self-citationVentral Tegmental Area Neurons in Learned Appetitive Behavior and Positive Reinforcement
Fields, H. L., Hjelmstad, G. O., Margolis, E. B., & Nicola, S. M. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094341 · Cited by 611 · see citing works
Placebo effects on human μ-opioid activity during pain
Wager, T. D., Scott, D. J., & Zubieta, J.-K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702413104 · Cited by 562 · see citing works
The neurobiology of social play behavior in rats
Vanderschuren, L. J. M. J., Niesink, R. J. M., & Van Pee, J. M. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00020-6 · Cited by 559 · see citing works
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
Mogil, J. S., & Pasternak, G. W. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01502-3 · Cited by 441 · see citing works
Role of brain dopamine in food reward and reinforcement
Wise, R. A. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.1854 · Cited by 436 · see citing works
Self-citationSpruijt, B. M., van den Bos, R., & Pijlman, F. T. A. (2001) · Applied Animal Behaviour Science · doi:10.1016/s0168-1591(00)00204-5 · Cited by 436 · see citing works
Fields, H. L., & Margolis, E. B. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.01.002 · Cited by 432 · see citing works
Goodman, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 412 · see citing works
Carlezon, W. A., Béguin, C., DiNieri, J. A., Baumann, M. H., Richards, M. R., Todtenkopf, M. S., Rothman, R. B., Ma, Z., Lee, D. Y.-W., & Cohen, B. M. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092304 · Cited by 390 · see citing works
Dunbar, R. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.10.004 · Cited by 380 · see citing works
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366 · see citing works
“In particular, dynorphins decrease and enkephalins increase the release of DA (Devine et al. 1993; Di Chiara & Imperato 1988; Longoni et al. 1991; Pentney & Gratton 1991; Spanagel et al. 1990a,b, 1992).”
BackgroundOpiate-like effects of sugar on gene expression in reward areas of the rat brain
Spangler, R., Wittkowski, K. M., Goddard, N. L., Avena, N. M., Hoebel, B. G., & LEIBOWITZ, S. F. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.02.013 · Cited by 255 · see citing works
Kappa opioid inhibition of morphine and cocaine self-administration in rats
Glick, S. D., Maisonneuve, I. M., Raucci, J., & Sydney, A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00306-b · Cited by 245 · see citing works
The endogenous opioid system: A common substrate in drug addiction
Trigo, J. M., Martín‐García, E., Berrendero, F., Robledo, P., & Maldonado, R. J. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.011 · Cited by 240 · see citing works
Dopamine receptors—physiological understanding to therapeutic intervention potential
Emilien, G. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00029-7 · Cited by 230 · see citing works
Shaham, Y., Rajabi, H., & Stewart, J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-05-01957.1996 · Cited by 214 · see citing works
Intracranial Self-Stimulation to Evaluate Abuse Potential of Drugs
Negus, S., & Miller, L. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007419 · Cited by 217 · see citing works
Ciccocioppo, R. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00302-0 · Cited by 203 · see citing works
Identification of Rat Ventral Tegmental Area GABAergic Neurons
Margolis, E. B., Toy, B. C., Himmels, P., Morales, M., & Fields, H. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042365 · Cited by 202 · see citing works
Fadda, P., Scherma, M., Fresu, A., Collu, M., & Fratta, W. (2003) · Synapse · doi:10.1002/syn.10238 · Cited by 197 · see citing works
Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2087-0 · Cited by 196 · see citing works
Wise, R. A., Leone, P., Rivest, R., & Leeb, K. (1995) · Synapse · doi:10.1002/syn.890210207 · Cited by 190 · see citing works
Self-citationEndogenous opioids: overview and current issues
Akil, H., Owens, C. E., Gutstein, H. B., Taylor, L. P., Curran, E. J., & Watson, S. J. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00071-4 · Cited by 180 · see citing works
Sexual Behavior and Sex-Associated Environmental Cues Activate the Mesolimbic System in Male Rats
Balfour, M. E., Yu, L., & Coolen, L. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300350 · Cited by 177 · see citing works
Volman, S. F., Lammel, S., Margolis, E. B., Kim, Y., Richard, J. M., Roitman, M. F., & Lobo, M. K. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3250-13.2013 · Cited by 168 · see citing works
Endogenous opioids and feeding behavior: a 30-year historical perspective
Bodnar, R. J. (2004) · Peptides · doi:10.1016/j.peptides.2004.01.006 · Cited by 170 · see citing works
Elman, I., Borsook, D., & Lukas, S. E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301051 · Cited by 169 · see citing works
Effects of Kappa Opioids on Cocaine Self-Administration by Rhesus Monkeys
Negus, S. S., Mello, N. K., Portoghese, P. S., & Lin, C. E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36769-2 · Cited by 169 · see citing works
Orphanin FQ/Nociceptin Modulation of Mesolimbic Dopamine Transmission Determined by Microdialysis
Murphy, N. P., & Maidment, N. T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730179.x · Cited by 167 · see citing works
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
Tejeda, H. A., Shippenberg, T. S., & Henriksson, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0844-x · Cited by 155 · see citing works
Kappa-opioid ligands in the study and treatment of mood disorders
Carlezon, W. A., Béguin, C., Knoll, A. T., & Cohen, B. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.008 · Cited by 156 · see citing works
Nicotine self-administration in animals as a dependence model
Corrigall, W. A. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011121 · Cited by 153 · see citing works
Corrigall, W., Coen, K. M., Adamson, K. L., Chow, B. L., & Zhang, J. (2000) · Psychopharmacology · doi:10.1007/s002139900355 · Cited by 152 · see citing works
Dopamine Reuptake Inhibition in the Rostral Agranular Insular Cortex Produces Antinociception
Burkey, A. R., Carstens, E. E., & Jasmin, L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04169.1999 · Cited by 151 · see citing works
Interactions between Kappa Opioid Agonists and Cocaine: Preclinical Studies
Mello, N. K., & Negus, S. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06678.x · Cited by 145 · see citing works
Lucas, L., Celen, Z., Tamashiro, K. L., Blanchard, R. J., Blanchard, D. C., Markham, C. M., Sakai, R. R., & McEwen, B. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.009 · Cited by 145 · see citing works
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys
Mello, N. K., & Negus, S. S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37657-8 · Cited by 141 · see citing works
Hyytiä, P., & Kiianmaa, K. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02123.x · Cited by 140 · see citing works
Motivation and Self-Regulation in Addiction: A Call for Convergence
Köpetz, C. E., Lejuez, C. W., Wiers, R. W., & Kruglanski, A. W. (2013) · Perspectives on Psychological Science · doi:10.1177/1745691612457575 · Cited by 138 · see citing works
Mapping of chemical trigger zones for reward
Ikemoto, S., & Wise, R. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.012 · Cited by 137 · see citing works
Self-citationSvingos, A. L., Chavkin, C., Colago, E. E. O., & Pickel, V. M. (2001) · Synapse · doi:10.1002/syn.10005 · Cited by 136 · see citing works
Tejeda, H. A., Counotte, D. S., Oh, E. J., Ramamoorthy, S., Schultz‐Kuszak, K., Bäckman, C. M., Chefer, V., O’Donnell, P., & Shippenberg, T. S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.76 · Cited by 132 · see citing works
Presynaptic Opioid and Nicotinic Receptor Modulation of Dopamine Overflow in the Nucleus Accumbens
Britt, J. P., & McGehee, D. S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4275-07.2008 · Cited by 125 · see citing works
Pearce, E., Wlodarski, R., Machin, A., & Dunbar, R. I. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700712114 · Cited by 131 · see citing works
Shippenberg, T. S., & Rea, W. P. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00450-9 · Cited by 130 · see citing works
Functional implications of glutamatergic projections to the ventral tegmental area
Geisler, S., & Wise, R. A. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.4-5.227 · Cited by 125 · see citing works
Self-citationBechtholt, A. J., & Cunningham, C. L. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.1.213 · Cited by 124 · see citing works
GABAergic MECHANISMS OF OPIATE REINFORCEMENT
Xi, Z. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.485 · Cited by 124 · see citing works
Marinelli, P. W., Quirion, R., & Gianoulakis, C. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1490-2 · Cited by 122 · see citing works
Kuzmin, A. V., Semenova, S., Gerrits, M. A. F. M., Zvartau, E. E., & van Ree, J. M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00961-2 · Cited by 122 · see citing works
Bontempi, B., & Sharp, F. R. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08596.1997 · Cited by 120 · see citing works
β-Endorphin and drug-induced reward and reinforcement
Roth‐Deri, I., Green-Sadan, T., & Yadid, G. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.06.003 · Cited by 117 · see citing works
The selective κ-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat
Lindholm, S., Werme, M., Brené, S., & Franck, J. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00368-5 · Cited by 116 · see citing works
Gray, A. M., Rawls, S. M., Shippenberg, T. S., & McGinty, J. F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731066.x · Cited by 116 · see citing works
Hipólito, L., Wilson‐Poe, A. R., Campos‐Jurado, Y., Zhong, E., González-Romero, J. L., Virag, L., Whittington, R. A., Comer, S. D., Carlton, S. M., Walker, B. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1053-15.2015 · Cited by 115 · see citing works
Young, K. A., Gobrogge, K. L., & Wang, Z. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.004 · Cited by 111 · see citing works
Brain Reward Circuits in Morphine Addiction
Kim, J., Ham, S., Hong, H., Moon, C., & Im, H. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0137 · Cited by 113 · see citing works
Tejeda, H. A., & Bonci, A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.09.023 · Cited by 112 · see citing works
Xi, Z., Fuller, S. A., & Stein, E. A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37186-1 · Cited by 107 · see citing works
Garzón, M., & Pickel, V. M. (2001) · Synapse · doi:10.1002/syn.1088 · Cited by 107 · see citing works
Ghrelin Interacts with Neuropeptide Y Y1 and Opioid Receptors to Increase Food Reward
Skibicka, K. P., Shirazi, R. H., Hansson, C., & Dickson, S. L. (2011) · Endocrinology · doi:10.1210/en.2011-1606 · Cited by 103 · see citing works
Regulation of the mesolimbic dopamine circuit by feeding peptides
Liu, S., & Borgland, S. L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.046 · Cited by 100 · see citing works
Yoshida, Y., Koide, S., Hirose, N., Takada, K., Tomiyama, K., Koshikawa, N., & Cools, A. R. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00046-9 · Cited by 102 · see citing works
The opioid system in depression
Jelen, L. A., Stone, J. M., Young, A. H., & Mehta, M. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104800 · Cited by 102 · see citing works
Valdez, G. R., Platt, D. M., Rowlett, J. K., Rüedi-Bettschen, D., & Spealman, R. D. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125484 · Cited by 99 · see citing works
Opioid propeptide mRNA content and receptor density in the brains of AA and ANA rats
Marinelli, P. W., Kiianmaa, K., & Gianoulakis, C. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00517-8 · Cited by 99 · see citing works
Modulation of drug-induced sensitization processes by endogenous opioid systems
Spanagel, R. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(94)00176-g · Cited by 98 · see citing works
The stimulatory effects of opioids and their possible role in the development of tolerance
Smart, D., & Lambert, D. G. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10023-7 · Cited by 99 · see citing works
Dual Roles of Dopamine in Food and Drug Seeking: The Drive-Reward Paradox
Wise, R. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.001 · Cited by 95 · see citing works
Self-citationJentsch, J. D., Tran, A., Taylor, J. R., & Roth, R. H. (1998) · Psychopharmacology · doi:10.1007/s002130050649 · Cited by 97 · see citing works
Svingos, A. L., Clarke, C. L., & Pickel, V. M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199910)34:1 · Cited by 67 · see citing works
Roth‐Deri, I., Zangen, A., Aleli, M., Goelman, R. G., Pelled, G., Nakash, R., Gispan-Herman, I., Green, T., Shaham, Y., & Yadid, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01584.x · Cited by 94 · see citing works
Elmer, G. I., Pieper, J. O., Rubinstein, M., Low, M. J., Grandy, D. K., & Wise, R. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-10-j0004.2002 · Cited by 94 · see citing works
Self-citationGiannuario, A. D., & Pieretti, S. (2000) · Peptides · doi:10.1016/s0196-9781(00)00250-3 · Cited by 90 · see citing works
Morani, A. S., Kivell, B. M., Prisinzano, T. E., & Schenk, S. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.09.002 · Cited by 89 · see citing works
Margolis, E. B., Fields, H. L., Hjelmstad, G. O., & Mitchell, J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4569-08.2008 · Cited by 87 · see citing works
Nylander, I., Vlaskovska, M. V., & Terenius, L. Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00279-y · Cited by 87 · see citing works
Hirose, N., Murakawa, K., Takada, K., Oi, Y., Suzuki, T., Nagase, H., Cools, A. R., & Koshikawa, N. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.065 · Cited by 86 · see citing works
Negus, S. S. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1878-7 · Cited by 86 · see citing works
The role of the opioid system in alcohol dependence
Nutt, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113504017 · Cited by 85 · see citing works
Bergevin, A., Girardot, D., Bourque, M.-J., & Trudeau, L. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00061-8 · Cited by 83 · see citing works
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81 · see citing works
Kilpatrick, M., Rooney, M. B., MICHAEL, D., & Wightman, R. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00578-3 · Cited by 80 · see citing works
Kotlinska, J. H., Wichmann, J., Łęgowska, A., Rolka, K., & Silberring, J. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200205000-00006 · Cited by 78 · see citing works
Mu‐opioid receptor knockout mice show diminished food‐anticipatory activity
Kas, M. J., van den Bos, R., Baars, A. M., Lubbers, M. E., Lesscher, H. M. B., Hillebrand, J. J., Schuller, A. G., Pintar, J. E., & Spruijt, B. M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03581.x · Cited by 77 · see citing works
Radioligand-binding study of noribogaine, a likely metabolite of ibogaine
Pearl, S. M., Herrick‐Davis, K., Teitler, M., & Glick, S. D. (1995) · Brain Research · doi:10.1016/0006-8993(95)00123-8 · Cited by 78 · see citing works
Salvinorin A: Allosteric Interactions at the μ-Opioid Receptor
Rothman, R. B., Murphy, D. L., Xu, H., Godin, J. A., Dersch, C. M., Partilla, J. S., Tidgewell, K. J., Schmidt, M. D., & Prisinzano, T. E. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.113167 · Cited by 76 · see citing works
Devine, D. P., Leone, P., & Wise, R. A. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90167-g · Cited by 75 · see citing works
Self-citationAberrant mesolimbic dopamine–opiate interaction in obesity
Tuominen, L. J., Tuulari, J. J., Karlsson, H., Hirvonen, J., Helin, S., Salminen, P. T. P., Parkkola, R. K., Hietala, J. A., Nuutila, P., & Nummenmaa, L. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.08.001 · Cited by 72 · see citing works
Gerrits, M. A. F. M., van Ree, J. M., Patkina, N. A., & Zvartau, E. E. (1995) · Psychopharmacology · doi:10.1007/bf02246059 · Cited by 73 · see citing works
Archer, S., Glick, S. D., & Bidlack, J. M. (1996) · Neurochemical Research · doi:10.1007/bf02532378 · Cited by 73 · see citing works
Wiskerke, J., Schetters, D., van Es, I. E., van Mourik, Y., den Hollander, B., Schoffelmeer, A. N. M., & Pattij, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4794-10.2011 · Cited by 68 · see citing works
David, V., Durkin, T., & Cazala, P. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0981-2 · Cited by 71 · see citing works
- Authors
- Devine, D. P., Leone, P., Pocock, D., & Wise, R. A.
- Affiliations
- Concordia University (CA)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1993-07
- Volume
- 266
- Issue
- 3
- Pages
- 1236-1246
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2108098398
- Cited by
- 382
- References
- 0
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 5 · 2017: 10 · 2016: 7 · 2015: 10 · 2014: 7 · 2013: 13 · 2012: 10
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institute on Drug Abuse (DA1720)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- ventral tegmental area, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, dopamine release, ventral striatum, dopamine metabolites, DAMGO, DPDPE, U50,488H, naltrindole, CTOP, mesolimbic dopamine system, opioid receptor selectivity, enkephalin, opioid agonists, opioid antagonists
- MeSH terms
- Amino Acid Sequence, Analgesics, Animals, Chromatography, High Pressure Liquid, Corpus Striatum, Dialysis, Dopamine, Enkephalins, Homovanillic Acid, Hydroxyindoleacetic Acid, Limbic System, Male, Microinjections, Molecular Sequence Data, Naltrexone, Narcotic Antagonists, Pyrrolidines, Rats, Inbred Strains, Receptors, Opioid, Tegmentum Mesencephali, 3,4-Dihydroxyphenylacetic Acid, 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Enkephalin, D-Penicillamine (2,5)-, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review